Clinical Trial Search

Primary: Effect of Exercise on Inflammation (C-reactive Protein) — 0.00; 0.05 mg/dL

Primary: Muscle Mass Via Dual-Energy X-ray Absortiometry (DEXA)Scan Data — 6104.45; 6355.3 grams — p=.318

Primary: 10-meter Walking Speed (m/Sec) — 0.165; 0.215; 0.13; 0.13 speed (m/sec)

Primary: Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS — 0.31; 0.43; 0.45; 0.65 millivolts (mV)

Primary: Change in Motor Evoked Potential (MEP) Amplitude in the Tibialis Anterior Muscle at the End of Training. — -1.75; -2.01 Amplitude percentage of Mmax

Primary: Physical Activity Level at Week 8 — 383; 297 Minutes per week

Primary: Bladder Storage — 278.5; 447.75; 580.5; 313.0 mLH2O

Primary: Change in Trabecular Plate Width (Tb.PW) for Femur and Tibia at 4.5 Months — 1785.42; 1819.41; 1805.52; 1834.67 μm

Primary: Walking Speed Change From Baseline — .054; .078; .085; .039 meters/second

Primary: Graded and Redefined Assessment of Strength, Sensibility and Prehension Test (GRASSP Test) — 4.5; 19.4 score change before and after — p=<0.000

Primary: Double-blind Change From Baseline in Ashworth Score Evaluating Spasticity — -0.19; -0.15 units on a scale

Primary: Change From Baseline in American Spinal Injury (ASIA) Upper Extremities Motor Score — 15.58; 12.63 Scores on a scale — p=0.55

Primary: Feasibility of Intraoperative Contrast-enhanced Ultrasound in Acute Traumatic Spinal Cord Injury - Number of Participants With Successful Intraoperative…

Primary: Functional Gait Assessment (FGA) — 15.22; 14.22; 19.38; 18.13 score on a scale — p=<0.001

Primary: Change in Walking Function - 10m Walk Walking Speed (m/s) — 0.06; 0.16 speed difference in meters per second

Primary: Double-blind Change From Baseline in Ashworth Score Evaluating Spasticity — -0.28; -0.16 units on a scale

Primary: Percent Change in Hmax — 27.85; 8.43; -4.91; 16.20 percent change in Hmax

Primary: Seated Systolic Blood Pressure — 86; 100.4; 102.7; 101.3 mmHg

Primary: Percent Body Fat Assessed by DXA at Baseline and 21 Weeks — 26.6; 25.9; 22.0; 25.6 % of body fat

Primary: Change in Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0)Score. — 7.08 units on a scale

Primary: VO2 Peak - Cardiorespiratory Fitness Change (Peak Oxygen Consumption Change) — 14.69; 14.36; 15.61; 13.74 ml/kg/min

Primary: Acute Gene Regulation: MSTN — 5.49; 4.76 arbitrary units — p=<0.001

Primary: Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Resistance — -0.692; 0.23 correlation coefficient — p=0.006

Primary: Muscle Weakness — 2; 3 Participants

Primary: Gait Speed With 10-Meter Walk Test — -10.24; -1.79 seconds — p=0.006

Primary: Change From Baseline in Exercise Capacity at 6 Months — 14.6; 18.5; 17.1; 13.9 ml/kg/min

Primary: Cervical Spine Injury — 274; 159 Participants — p=.05

Primary: Number of Participants Demonstrating 10% Change: Arm Ergometer and Lokomat Metabolic Cart VO2 Peak — 17; 13; 17; 12 participants

Primary: Physiological Cost Index (PCI) Ratio — 3.34 unit less

Primary: Electromyographic Responses (Active)